168 related articles for article (PubMed ID: 51012)
1. Restoration of specific immunity against SV40 tumor-specific transplantation antigen to lymphoid cells from tumor-bearing mice.
Blasecki JW; Tevethia SS
Int J Cancer; 1975 Aug; 16(2):275-83. PubMed ID: 51012
[TBL] [Abstract][Full Text] [Related]
2. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
Blasecki JW; Tevethia SS
J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
[TBL] [Abstract][Full Text] [Related]
3. Induction of simian virus 40 (SV40) transplantation immunity in mice by SV40-transformed cells of various species.
Law LW; Takemoto KK; Rogers MJ; Ting RC
J Natl Cancer Inst; 1977 Nov; 59(5):1523-6. PubMed ID: 198568
[TBL] [Abstract][Full Text] [Related]
4. Generation of cytotoxic lymphocytes by SV40-induced antigens.
Chang C; Chang R; Mora PT; Hu CP
J Immunol; 1982 May; 128(5):2160-3. PubMed ID: 6278025
[TBL] [Abstract][Full Text] [Related]
5. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). I. Specificity of immunoprotection and effect of enzyme treatment on TSTA activity.
Ansel S; Huet C; Tournier P
Int J Cancer; 1977 Jul; 20(1):51-60. PubMed ID: 71274
[TBL] [Abstract][Full Text] [Related]
6. Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice.
Law LW; Takemoto KK; Rogers MJ; Henriksen O; Ting RC
Int J Cancer; 1978 Sep; 22(3):315-22. PubMed ID: 212373
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immunity to virus-induced tumors: generation of lymphocytes sensitized to specific transplantation antigen in mouse cells infected with papovavirus SV40.
Tevethia SS; Tevethia MJ
Prog Med Virol; 1975; 21():103-17. PubMed ID: 174151
[No Abstract] [Full Text] [Related]
8. Subcellular distribution of the tumor-specific transplantation antigen of simian virus 40-transformed cells.
Rogers MJ; Law LW; Appella E
J Natl Cancer Inst; 1977 Oct; 59(4):1291-5. PubMed ID: 198559
[TBL] [Abstract][Full Text] [Related]
9. Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. I. Development of cellular immunity to simian virus 40 tumor-specific transplantation antigens during tumorigenesis by transplanted cells.
Zarling JM; Tevethia SS
J Natl Cancer Inst; 1973 Jan; 50(1):137-47. PubMed ID: 4348218
[No Abstract] [Full Text] [Related]
10. Quantitative in vivo studies of soluble simian virus 40 tumor-specific transplantation antigens of the mouse.
Henriksen O; Law LW; Appella E
J Natl Cancer Inst; 1977 Jun; 58(6):1785-8. PubMed ID: 194045
[TBL] [Abstract][Full Text] [Related]
11. Induction of SV40-related transplantation immunity in mice by BK virus-transformed cells.
Kato K; Iwamura Y; Kurimura T
Jpn J Med Sci Biol; 1979 Oct; 32(5):311-4. PubMed ID: 94612
[TBL] [Abstract][Full Text] [Related]
12. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). II. Association of SV40-TSTA activity with liposomes containing VSV glycolipids.
Huet C; Ansel S
Int J Cancer; 1977 Jul; 20(1):61-6. PubMed ID: 71275
[TBL] [Abstract][Full Text] [Related]
13. The importance of dose and proliferation of SV40-transformed cells with different oncogenic potentials to the level of tumor immunity.
Stillström J
Int J Cancer; 1974 Mar; 13(3):273-85. PubMed ID: 4362607
[No Abstract] [Full Text] [Related]
14. Tumor-specific transplantation antigen: use of the Ad2+ND1 hybrid virus to identify the protein responsible for simian virus 40 tumor rejection and its genetic origin.
Jay G; Jay FT; Chang C; Friedman RM; Levine AS
Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3055-9. PubMed ID: 80009
[TBL] [Abstract][Full Text] [Related]
15. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
Bright RK; Shearer MH; Kennedy RC
J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
[TBL] [Abstract][Full Text] [Related]
16. SV40 transplantation antigen: relationship to SV40-specific proteins.
Tevethia SS; Greenfield RS; Flyer DC; Tevethia MJ
Cold Spring Harb Symp Quant Biol; 1980; 44 Pt 1,():235-42. PubMed ID: 6253137
[No Abstract] [Full Text] [Related]
17. Relationship between T-antigen and tumor-specific transplantation antigen in simian virus 40-transformed cells.
Chang C; Martin RG; Livingston DM; Luborsky SW; Hu CP; Mora PT
J Virol; 1979 Jan; 29(1):69-75. PubMed ID: 219235
[TBL] [Abstract][Full Text] [Related]
18. Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. II. Tumor transplantation studies.
Ting CC; Rodrigues D; Herberman RB
Int J Cancer; 1973 Sep; 12(2):519-23. PubMed ID: 4134567
[No Abstract] [Full Text] [Related]
19. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
Newmaster RS; Mylin LM; Fu TM; Tevethia SS
Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
[TBL] [Abstract][Full Text] [Related]
20. Immunogenic properties of a soluble tumor rejection antigen (TSTA) from a Simian virus 40-induced sarcoma.
Rogers MJ; Law LW
Int J Cancer; 1979 Jan; 23(1):89-96. PubMed ID: 83307
[No Abstract] [Full Text] [Related]
[Next] [New Search]
